Cargando…
Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel
BACKGROUND: Contemporary antiretroviral therapies (ART) and management strategies have diminished both human immunodeficiency virus (HIV) treatment failure and the acquired resistance to drugs in resource-rich regions, but transmission of drug-resistant viruses has not similarly decreased. In low- a...
Autores principales: | Günthard, Huldrych F, Calvez, Vincent, Paredes, Roger, Pillay, Deenan, Shafer, Robert W, Wensing, Annemarie M, Jacobsen, Donna M, Richman, Douglas D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321850/ https://www.ncbi.nlm.nih.gov/pubmed/30052811 http://dx.doi.org/10.1093/cid/ciy463 |
Ejemplares similares
-
A Comparison of Initial Antiretroviral Therapy in the Swiss HIV Cohort Study and the Recommendations of the International AIDS Society-USA
por: Wandeler, Gilles, et al.
Publicado: (2011) -
Can we trust the guidelines? Comparison between the data presented and the recommendations of the International Antiviral Society-USA Panel
por: Jan Piso, Rein
Publicado: (2014) -
Recommendations on data sharing in HIV drug resistance research
por: Inzaule, Seth C., et al.
Publicado: (2023) -
Combination antiretroviral therapy and cell–cell spread of wild-type and drug-resistant human immunodeficiency virus-1
por: Titanji, Boghuma Kabisen, et al.
Publicado: (2017) -
Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial
por: Derache, Anne, et al.
Publicado: (2019)